Hyperkalemia: Guideline-Directed Therapy in CKD from Diabetes 1.0 CE hour 

Current Status
Not Enrolled
Get Started

Welcome to the course

Patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) risk progressing to kidney failure and experiencing severe cardiac adverse events. 

Current treatments aim to reduce these risks by controlling both hypertension and hyperglycemia. 

Link Inextricably T2D and CKD with cardiovascular disease, and many patients with diabetic kidney disease will also suffer from either hypertension or heart failure. 

Patients with diabetic kidney disease are at a higher risk of developing hyperkalemia, and in this course, we explore the most frequent causes.  

In addition, hyperkalemia development often leads to discontinuing one or more treatments, leaving patients even more vulnerable to disease progression.

This course should take you 30-60 minutes to complete: 1 CE hour

CE Activity

  • CME Released: 01/03/2022
  • Valid for credit through 01/03/2023

You Are Eligible For

  • BONENT Group A 1.0 Credit(s)™

Accreditation Statements

Floridian College Corp DBA: Floridian Institute is accredited by the Board of Nephrology Examiner Nursing and Technology (BONENT) to provide continuing medical education for nurses and technicians.

bonent accredited CEU